Disclosure

Editorial independence

Editorial decisions on ProPeptideGuide — what to cover, how to cover it, what to omit, what to update, what to retract — are made independently of any commercial relationship. No sponsor, advertiser, or affiliate partner reviews content before publication, and no commercial party has the ability to require, modify, or suppress coverage.

Affiliate relationships

Some peptide pages include an "Available Through" section that lists FDA-compliant telehealth platforms readers can use to discuss the therapy with a licensed prescriber. ProPeptideGuide may receive a referral fee when a reader signs up through one of these links.

Compensation does not influence whether a peptide is covered, the tone of coverage, or the providers listed. We do not list providers that fail our compliance review, regardless of the compensation offered. The existence of an affiliate relationship is disclosed inline on every page where it applies.

Microinfluencer revenue share

ProPeptideGuide operates a revenue-share program with content creators who add propeptideguide.com links to their published material. The creator receives 85% of net referral revenue attributed to their links; ProPeptideGuide retains 15%. Participation in the revenue-share program does not entitle a creator to influence editorial coverage.

Future medical advisory board

We are building toward a named medical advisory board whose members will sign individual pages as they review them. As reviewers are added, this page will be updated with each member's name, credentials, areas of focus, and disclosed conflicts. Until that board exists, no page on this site claims medical review.

Funding and ownership

This section will be updated when the operating entity, ownership structure, and any institutional funding are finalized.